A Phase 3, Single-Arm Study of CG0070 in Subjects with Non-Muscle Invasive Bladder Cancer (NMIBC) Unresponsive to Bacillus Calmette-Guerin (BCG)

被引：0
|
作者：
Uchio, Edward [1 ]
Lamm, Donald [2 ]
Anderson, Paul D. [3 ]
Tran, Ben [4 ]
Kamat, Ashish [5 ]
McAdory, John [6 ]
Keel, Melody [6 ]
Grandi, Paola [6 ]
Burke, James [6 ]
机构：
[1] Univ Calif Irvine, Irvine, CA USA
[2] BCG Oncol, Phoenix, AZ USA
[3] Royal Melbourne Hosp, Melbourne, Vic, Australia
[4] Peter MacCallum Canc Ctr, Melbourne, Vic, Australia
[5] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[6] CG Oncol, Irvine, CA USA
来源：
MOLECULAR THERAPY | 2021年 / 29卷 / 04期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
659
引用
收藏
页码：320 / 320
页数：1
相关论文
共 50 条
  • [31] LONG-TERM COST-EFFECTIVENESS OF NADOFARAGENE FIRADENOVEC AND OPORTUZUMAB MONATOX FOR TREATMENT OF BACILLUS CALMETTE-GUERIN (BCG)-UNRESPONSIVE, NON-MUSCLE INVASIVE BLADDER CANCER (NMIBC)
    Joshi, M.
    Atlas, S. J.
    Rind, D. M.
    Beinfeld, M.
    McKenna, A.
    Patel, S.
    Chapman, R. H.
    Pearson, S.
    Touchette, D.
    VALUE IN HEALTH, 2021, 24 : S33 - S33
  • [32] Outcomes of Intravesical Bacillus Calmette-Guerin (BCG) in patients with Non-Muscle Invasive Bladder Cancer: A retrospective study in Australia
    Pillippuhewa, Chamodi
    Della-Fiorentina, Stephen
    Haghighi, Kayvan
    Chau, Wei
    Kok, Peey-Sei
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2021, 17 : 61 - 61
  • [33] Predictive biomarkers of response to bacillus Calmette-Guerin immunotherapy and bacillus Calmette-Guerin failure for non-muscle invasive bladder cancer
    Wang, Ziting
    So, Wei Zheng
    Loh, Kep Yong
    Lim, Yew Koon
    Mahendran, Ratha
    Wu, Qing Hui
    Chiong, Edmund
    INTERNATIONAL JOURNAL OF UROLOGY, 2022, 29 (08) : 807 - 815
  • [34] Impact of Bacillus Calmette-Guerin (BCG) shortage on the management of high risk non-muscle invasive bladder cancer: a single centre study
    Huang, D.
    Perera, M.
    Khan, M.
    Lawrentschuk, N.
    Newbold, R.
    Sengupta, S.
    BJU INTERNATIONAL, 2018, 121 : 82 - 83
  • [35] Treatment of non-muscle invasive bladder cancer with Bacillus Calmette-Guerin (BCG): Biological markers and simulation studies
    Kiselyov, Alex
    Bunimovich-Mendrazitsky, Svetlana
    Startsev, Vladimir
    BBA CLINICAL, 2015, 4 : 27 - 34
  • [36] Smoke load prognostic impact on bacillus Calmette-Guerin (BCG) treated non-muscle invasive bladder cancer
    Andrade, Danilo Leite
    Moretti, Tomas Bernardo Costa
    Neto, Wilmar Azal
    Benedetti, Julia
    Reis, Leonardo Oliveira
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2020, 52 (08) : 1471 - 1476
  • [37] A PHASE II/III TRIAL OF CG0070, AN ONCOLYTIC ADENOVIRUS, FOR BCG-REFRACTORY NON-MUSCLE-INVASIVE BLADDER CANCER (NMIBC)
    Packiam, Vignesh T.
    Campanile, Alexa N.
    Barocas, Daniel A.
    Chamie, Karim
    Davis, Ronald L., III
    Kader, A. Karim
    Lamm, Donald L.
    Yeung, Alex W.
    Steinberg, Gary D.
    JOURNAL OF UROLOGY, 2016, 195 (04): : E142 - E142
  • [38] Letter to the Editor: Bacillus Calmette-Guerin (BCG) Treatment Failures with Non-Muscle Invasive Bladder Cancer: A Data-Driven Definition for BCG Unresponsive Disease
    Li, Roger
    Sylvester, Richard
    Dinney, Colin P.
    Kamat, Ashish M.
    BLADDER CANCER, 2017, 3 (03) : 147 - 148
  • [39] An open label, single-arm, phase II multicenter study of the safety and efficacy of CG0070 oncolytic vector regimen in patients with BCG-unresponsive non muscle-invasive bladder cancer: Interim results
    Packiam, Vignesh T.
    Lamm, Donald L.
    Barocas, Daniel A.
    Trainer, Andrew
    Fand, Benjamin
    Davis, Ronald L., III
    Clark, William
    Kroeger, Michael
    Dumbadze, Igor
    Chamie, Karim
    Kader, A. Karim
    Curran, Dominic
    Gutheil, John
    Kuan, Arthur
    Yeung, Alex W.
    Steinberg, Gary D.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2018, 36 (10) : 440 - 447
  • [40] Treatment strategies for the Bacillus Calmette-Guerin-unresponsive non-muscle invasive bladder cancer
    Jeong, Seung-hwan
    Ku, Ja Hyeon
    INVESTIGATIVE AND CLINICAL UROLOGY, 2023, 64 (02) : 103 - 106
12345